Capital One Financial Corp. vs McKesson Corporation — how do they compare? Capital One Financial Corp. trades at $219.5 (market cap $134.45B), while McKesson Corporation trades at $894.99 (market cap $105.14B). The key difference: Capital One Financial Corp. is the larger of the two by market cap, and Capital One Financial Corp. pays the higher dividend (1.46%). Which is the better fit depends on your goals.
| COF | MCK | |
|---|---|---|
Market Cap | $134.45B | $105.14B |
Sector | Financials | Health |
52-Week High | $257.94 | $995.69 |
52-Week Low | $176.10 | $659.01 |
Dividend Yield | 1.46% | 0.42% |
Enterprise Value | — | $111.67B |
Signals from Pluang's Aura AI — not financial advice
Capital One Financial (COF) trades at $218.97, up 0.56% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $251.60. Recent Q2 2026 earnings beat expectations with EPS of $5.81, while revenue growth accelerated to $53.43B in 2025. The Discover integration is on track, targeting $2.5B in synergies by late 2027, supporting double-digit EPS growth projections.
The outlook is positive, driven by strong card growth, technology advantages, and merger synergies, but risks include integration execution, credit loss provisions, and macroeconomic sensitivity. With a P/E of 12.07 and 63% analyst buy ratings, the stock offers value if Discover benefits materialize as planned.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →